Qube Research & Technologies Ltd - ADAMAS PHARMACEUTICALS INC ownership

ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 66 filers reported holding ADAMAS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 2.80 and the average weighting 0.1%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of ADAMAS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$112,000
+96.5%
25,823
+87.2%
0.00%
+100.0%
Q3 2020$57,000
-9.5%
13,797
-43.9%
0.00%0.0%
Q2 2020$63,00024,6090.00%
Other shareholders

There were no reported owners of ADAMAS PHARMACEUTICALS INC in Q4 2020.

NameSharesValueWeighting ↓
View complete list of ADAMAS PHARMACEUTICALS INC shareholders